The first needle-free emergency treatment for anaphylaxis – in the form of a nasal spray – will now be available in the UK.

Esketamine monotherapy demonstrated beneficial antidepressant effects at multiple doses for patients with treatment-resistant depression, according to results of a phase 4 randomized trial published ...